 | Up a level |
Turco, L; Villanueva, C; La Mura, V; García-Pagán, J C; Reiberger, T; Genescà, J; Groszmann, R J; Sharma, B C; Merkel, C; Bureau, C; Alvarado, E; Abraldes, J G; Albillos, A; Bañares, R; Peck-Radosavljevic, M; Augustin, S; Sarin, S; Bosch, Jaime; García-Tsao, Guadalupe (2020). Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis. Clinical gastroenterology and hepatology, 18(2), 313-327.e6. Elsevier 10.1016/j.cgh.2019.05.050
Koeberle, D; Dufour, Jean-François; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Bühlmann, Michael; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer, SAKK (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of oncology, 27(5), pp. 856-861. Oxford University Press 10.1093/annonc/mdw054
